Zum Inhalt springen
AI.info

AI Tools

Origin-1

Origin-1: Preise, Fähigkeiten, Updates und Alternativen, von den Seiten des Anbieters gelesen.

Die Website von Origin-1

Auf Englisch

Key facts

Price
Not stated on the maker’s pages
Free plan
Not stated on the maker’s pages
Platforms
Not stated on the maker’s pages
API
Not stated on the maker’s pages
Open source
Yes · MIT Read on github.com

Origin-1 designs monoclonal antibodies for “zero-prior” epitopes—target sites without reported structures of antibody or other protein binders. Absci describes a workflow that generates antibody structures and sequences, then scores and filters candidates. It is intended for therapeutic discovery and lead identification.

The system combines AbsciDiff for structure generation, IgDesign2 for antibody sequence design, and AbsciBind for candidate scoring. Absci reports validation with laboratory assays; generated designs are candidates, not experimentally confirmed results by themselves. The public repository contains study data and model artifacts, but Absci’s site does not list commercial access terms or prices.

Category
Research & Education
Read from the maker’s pages
2026-11-18

Company

Absci Corporation

Features

  • Generates antibody–antigen structures conditioned on antigen structure and user-defined epitopes.
  • Designs all six antibody complementarity-determining regions.
  • Models heavy- and light-chain sequence design together.
  • Scores and filters antibody candidates before experimental testing.
  • Includes a public repository of study data and model artifacts under the MIT license.
  • Reports validation using SPR, BLI, size-exclusion chromatography, and developability screening.

Use cases

  • Design antibody candidates for target sites without known protein binders.
  • Explore epitope-specific binders for targets lacking solved complex structures.
  • Rank and filter antibody designs before laboratory testing.
  • Prioritize antibody candidates for specificity and developability assays.
  • Use published model artifacts and study data to examine reported designs.

Questions about Origin-1

Is Origin-1 open source?

Yes. The code of Origin-1 is published at github.com/AbSciBio/origin-1 under the MIT licence. Read on the maker’s pages on 18 Nov 2026.

Is Origin-1 still available?

Yes, as of 18 Nov 2026: its maker’s pages were read that day and carried no notice that Origin-1 has ended.

Sources

Not confirmed

Prices
No official Origin-1 pricing page was found in the search or Absci pages reviewed.
No official pricing page with readable prices was found.
No official price was found.
Free plan
The pages reviewed do not state whether commercial access has a free tier.
API
The product and repository pages reviewed do not confirm an API.
Platforms
The pages reviewed do not specify end-user software platforms.
Latest version
No separate current product version or model version was stated.
Official website